BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes.
Yu-Li ChenHan-Wei LinChung-Liang ChienYen-Ling LaiWei-Zen SunChi-An ChenWen-Fang ChengPublished in: Journal for immunotherapy of cancer (2019)
The Trial Registration Number was NCT00854399.